Skip to main navigation Skip to search Skip to main content

Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-Month experience

  • Ari Zimran
  • , Gheona Altarescu
  • , Mici Philips
  • , Drorit Attias
  • , Marina Jmoudiak
  • , Maher Deeb
  • , Nan Wang
  • , Kiran Bhirangi
  • , Gabriel M. Cohn
  • , Deborah Elstein*
    • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

125 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-Month experience'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science